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Efficient energy metabolism is a fundamental biochemical
requirement which is approached in different ways by different
organisms [reviewed in 1]. Many bacteria, for instance, are able to
live in diverse chemical environments. In hypoxia they can regu-
late gene expression to provide enzymatic systems which utilize a
variety of alternate electron acceptors such as nitrate, or fumarate
instead of the more energetically efficient oxygen. In higher
animals alternate electron acceptors are not used in this way and
some form of aerobic environment is obligatory. A variety of
specialized systems (lungs, heart, vessels and blood) have evolved
to provide oxygen in optimal concentrations for cellular respira-
tion. Since oxygen in excess is potentially toxic, the matching of
oxygen supply with cellular metabolism must be precise. Compar-
ative anatomists and physiologists have demonstrated many ex-
amples of this precision. For instance, among muscles from
different species and different parts of the body, there is a striking
concordance of measures of capillary and mitochondrial volume
density, implying a close coordination of oxygen supply and
demand [21. Despite the detail of this type of organization, which
is seen in the gross anatomy of species with different athletic
specialization, in metabolic zonation within organs such as liver
and kidney [3], and in the disposition of organelles within cells,
physiological texts dealing with oxygen sensing have tended to
stress the importance of chemoreceptors with control over major
functions such as ventilatory rate, cardiac output, or red cell
production. Relatively little consideration has been given to the
implications of the detailed organization of oxygen supply and
demand at the microscopic level for cellular oxygen sensing. It
now seems likely that recent advances arising from the study of
one of the major systemic regulators, erythropoietin production,
may also shed light on the transcriptional processes underlying
these local responses to oxygenation.
Studies of erythropoietin regulation
The study of any sensing mechanism is predicated on the
existence of a dynamic response that is easily measured. It was the
unusual, or even unique, hormonal operation of the hcmatopoi-
etic growth factor erythropoietin which enabled the classical
physiological studies on which the concept of an underlying
oxygen sensor was established. These experiments showed that
production of erythropoietin was increased by reduction in blood
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oxygen availability (which might arise from reduced arterial P°2
or increased hemoglobin affinity as well as anemia), but that
beyond this, the stimulus response range is extremely narrow
[reviewed in 4]. For instance, production is not increased by
metabolic inhibitors such as cyanide [5, 6] or stresses such as heat
shock, indicating that the system is most likely responding to
hypoxia itself rather than some secondary consequence of im-
paired cellular respiration or cell damage.
Cloning of the eiythropoietin gene opened the way for further
studies of the regulatory process. Increased production is based
on new protein synthesis [7] arising at least in part from increased
gene transcription [8]. Oxygen dependent erythropoietin gene
expression can be observed in the tissue culture hepatoma cell
lines Hep3B and HepG2, providing a tissue culture model of the
system [9]. Studies in these cells established certain distinctive
features of the inducible mechanism. Induction of gene expression
is blocked by cycloheximide, implying and that new protein
synthesis is required at some point in the activation mechanism.
As is observed in vivo [10], erythropoietin production and eryth-
ropoietin gene expression in the hepatoma cells is induced by
certain metal ions (cobalt, manganese and nickel) [9]. Gene
expression is also induced by the exposure of cells to different
types of highly selective iron chelators [11, 12]. These distinctive
features of the inducible response, which are clearly represented
in a tissue culture system, have an led many investigators to
approach analysis of the regulatory mechanism from a consider-
ation of the gene itself.
One of the first steps in this approach is to define the control
sequences at the eiythropoietin locus that mediate the oxygen
regulated expression. Using transient transfection of hepatoma
cells, we and others defined a control sequence lying 3' to the gene
which could confer oxygen regulated expression on heterologous
reporter genes [13--is]. Although transient transfection studies
very convincingly demonstrated the importance of this sequence,
it is most probably only one of several elements mediating
regulation of the erythropoietin gene, other controls being ex-
erted through sequences 5' to the gene [16] or through mRNA
stability [17]. What was important for understanding the under-
lying mechanism of oxygen sensing and signal transduction was
that operation of this element, termed the eiythropoietin 3'
enhancer, reproduced the main features of regulation of the
endogenous gene rather precisely. Thus both the enhancer and
the endogenous gene could be activated by cohaltous ions and
iron chelating agents, as well as hypoxia, and the enhancer showed
the same narrow stimulus response characteristic that had been
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Fig. 1. The eiythropoietin 3' enhancer confers responses to hypoxia in both eiythropoietin producing cell types (Hep3B, hepatoma) and non-eiythropoietin
producing cell types (U937, monocyte; MRC5, lung fibroblast; IBR3, skin fibroblast). (A) Schematic (not to scale) showing the erythropoietin 3' enhancer
linked to the cs-globin reporter gene. (B) Expression of reporter (a) and control (FGH) plasmids in transfected cells. Alternate lanes are from hypoxic
and normoxic cells. Alternate pairs of lanes show results for reporter plasmids containing (+) or not containing (—) theeiythropoietin 3' enhancer. Data
are from [19].
defined for the endogenous gene, an inducible response being
observed with hypoxia but not exposure to inhibitors of mitochon-
drial respiration or cell stresses such as heat shock. These studies
indicated that analysis of regulatory mechanisms underlying acti.
vation of the 3' enhancer could be expected to shed light on
physiologically relevant sensing and signal transduction pathways.
An important step was therefore the identification of HIF-1 as a
DNA binding transcriptional complex which was critical for
enhancer function [18].
A widely operative system of gene regulation by oxygen
Studies of cis-acting elements
Though the definition of a regulatory clement by transfection of
erythropoietin producing hepatoma cells was a useful step to-
wards understanding the mechanism of regulation by oxygen, it
was not unexpected. Implicit in the regulation of the erythropoi-
ctin gene in these cells, was the existence of sequences which
could convey the response. What was more surprising was that the
erythropoietin 3'cnhancer defined in these experiments was able
to convey similar oxygen regulated responses when transfected
into a wide variety of other cells which do not express the
erythropoietin gene and were not derived from tissues which
make the hormone [191. An example of such an experiment is
illustrated in Figure 1. In each of the cell types, the expression of
two plasmids was compared; one plasmid contained 96 base pairs
from the mouse eiythropoietin 3' enhancer linked to a human
Table 1. Some processes in which functional similarities with
erythropoietin regulation have been defined or gene regulation by HIF-
1 has been demonstrated
Endothelial nitric oxide synthase [30];
endothelin [29, 31]; platelet-derived
growth factor [27, 28]
Vascular endothelial growth factor [23,
25—27]; placental growth factor,
platelet-derived growth factor,
transforming growth factor 13 [12]
Transforming growth factor 13 [12];
inducible nitric oxide synthase [78]
Glucose transporters [34]; glycolytic
enzymes [22, 32, 33, 35];
gluconcogenesis (phosphoenolpyruvate
carboxykinase) [36, 37]
Adenylate kinase-3 [38]
Tyrosine hydroxylase [39]
Duodenal iron uptake [41]; transferrin
[40]
a-globin reporter gene, the other was identical except for omis-
sion of the 96 base pair sequence. In the erythropoietin producing
Hep3B cells (lanes 1 to 4) a large increase in reporter gene
expression was observed in hypoxic cells (lane 2), which was
dependent on the presence of the eiythropoietin 3' enhancer.
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Fig. 2. Regulation of TGF/3,mRNA by hypoxia
and iron chelation. Abbreviations are: N,
normoxia (20% oxygen); H, hypoxia (1%
oxygen); DFO, desferrioxamine (100 jm). The
inducible responses are cell type specific and
are seen in the placental cell line, BeWo, but
not the hepatoma cell line, Hep3B.
Hybridization to U6 small nuclear RNA
(snRNA) is used as an internal control. Data
are from [121.
Essentially identical responses could be seen in the non-erythro-
poietin producing cells from lung, ovary, and skin, When different
conditions of stimulation were tested, similar responses were
again observed in the different cell types. As with the endogenous
erythropoietin gene, responses to hypoxia could be mimicked by
cobalt but not by respiratory chain inhibitors. The response was
blocked by cycloheximide implying that in some way new protein
synthesis was required, and the same narrow stimulus response
pattern was observed, with no response to cell stresses such as
heat shock. The findings indicated that an identical or closely
similar sensing and signal transduction system was present in all
the cells, and that it could interact with DNA sequences within the
erythropoietin 3' enhancer. The implication was that the system
was operating on other genes in non-erythropoietin producing
cells and that such genes should possess similar DNA control
sequences. Shortly after this finding, it was demonstrated that the
inducible transcription factor HIF-1, which had been shown to be
critical for the operation of the eiythropoietin 3' enhancer in
hepatoma cells, was indeed widely expressed [20, 21]. Subsequently,
other genes were defined that showed hypoxically inducible charac-
teristics similar to erythropoietin, and detailed examination of the
cis-acting control elements by transient transfection, and DNA
binding studies did demonstrate that FIIF-1 binding sites were
important in conveying these responses. Perhaps surprisingly, the
first of these turned out to be genes involved in glucose metabo-
lism: phosphoglycerate kinase-1, and lactate dehydrogenase-A
(LDH-A) [22]. That such genes so functionally dissimilar from
erythropoietin were linked to a common control system suggested
that this system of gene regulation might be very widely operative
in biology. Accordingly, a large number of genes have now been
identified that show functionally similar inducible responses to
erythropoietin (for instance, induction by cobaltous ions and iron
chelation as well as hypoxia) or where functional characterization
of the regulatory elements has demonstrated the importance of
HIF-1 binding sites. These genes include examples encoding
products involved in vascular growth [12, 23—27], vasomotor
control [27—31], wound repair [121, glucose transport and metab-
olism [22, 32—37], high energy phosphate metabolism [38], cate-
cholamine metabolism 1391, and iron metabolism [40, 411 (Table
1). It has become clear that closely similar mechanisms of oxygen
sensing and transcriptional activation are operating on genes that
appear to be involved in many medically important physiological
and pathophysiological processes.
Though the relevance of oxygen supply to all these processes is
clear, it is not immediately obvious how the same or even a very
similar mechanism of sensing and transcriptional activation could
satisfy the precise requirements of regulated gene expression in
such diverse systems. For some genes, the inducible response is
cell type specific. Surprisingly, this specificity for the inducible
response is seen even among cells showing substantial basal levels
of gene expression [121. Figure 2 shows an example for transform-
ing growth factor f3 (TGF/31). The regulation of TGFJ31 mRNA
was shown to be similar to erythropoietin mRNA in that an
inducible response was observed to both hypoxia and iron chelat-
ing agents. These inducible responses were observed in the
placental cell line BeWo, but not Hep3B cells, despite a similar
level of basal expression in Hep3B cells and the well established
operation of similar inducible responses for many other genes in
Hep3B cells. Presumably permissive transcriptional controls exist
enabling the inducible mechanisms to operate on different genes
in different cell types. Such mechanisms might also explain some
of the differences that have been observed between gene regula-
tion in transformed tissue culture cell lines and gene regulation in
intact organs [42]. In general terms, the precise regulation of
tissue specific and inducible gene transcription is thought to he
dependent on the variability that can produced by combined
interactions between multiple transcription factors [43]. Some
insight as to how this might he achieved in this system has been
provided by detailed mutational analysis of the cis-acting ele-
ments. For the two oxygen regulated cis-acting sequences that
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have been analyzed in detail by scanning mutations (the erythro-
poietin 3' enhancer [16, 18, 44] and the LDH-A promoter [45]),
activity is critically dependent on three sites: the HIF-1 recogni-
tion sequence, and two other sequences. For the erythropoietin
3'enhancer, one of these sites has been identified as binding the
tissue-specific transcription factor, hepatic nuclear factor-4
(HNF-4) [46]. In the case of the LDH-A promoter one of the
other critical sites conforms to the consensus sequences for a
cAMP response element (CRE) [45]. Neither the HNF-4 binding
site nor the CRE appear to convey inducible responses to hypoxia
themselves. In each case mutation at these sites abolishes or
severely reduces the inducible activity of the natural enhancer,
although artificial enhancers composed of multimers of the
shorter sequences omitting these sites, but retaining the HIF-1
site, are active [18, 44, 45]. Thus it appears likely that these
co-operative factors influence the transcriptional activity of the
HIF-1 complex in a way which contributes to shaping of the
overall characteristics of inducible and tissue specific gene expres-
sion.
Another phenomenum among oxygen regulated genes requir-
ing explanation is that for some of the genes showing similarities
to erythropoietin in the hypoxically inducible response, the range
of inducing stimuli is much broader [34, 47]. As an example of
such a gene we have analyzed the regulation of glucose transport-
er-i (glut-i) [34]. Glut-i is known to be inducible by mitochon-
drial inhibitors as well as hypoxia, perhaps implying a fundamen-
tally different mechanism of regulation [48]. However, we found
that glut-i mRNA could be induced by exposure of cells to cobalt
and iron chelators, as well as hypoxia and mitochondrial inhibi-
tors. Therefore, there were both similaries to, and differences
from, erythropoietin regulation. When the glut-I 5' enhancer was
coupled to a reporter gene all these properties were conferred on
the reporter implying that all effects were mediated by this
sequence. Detailed deletional and mutational analysis of the
enhancer, however, demonstrated that different regions conferred
the different responses (Fig. 3). Induction by hypoxia, cobaltous
ions, and iron chelation was found to be critically dependent on a
HIF-1 binding site in the 3' portion of the enhancer, whereas the
responses to mitochondrial inhibitors were mainly dependent on a
serum response element lying approximately 100 base pairs 5' to
this site. It thus appears that the characteristics of glut-I regula-
tion are built up from the combined action of different regulators.
This type of interaction is different from that occurring in the
erythropoietin and LDH-A control sequences, since in the glut-i
enhancer both the hypoxia responsive sequences and those re-
sponsive to mitochondrial inhibitors could function indepen-
dently. This implies that there are different classes of combinato-
rial interaction between transcription factors and transcriptional
complexes.
Ilypoxically inducible gene expression in mutant cells
In addition to HIF-i, regulation by hypoxia or related metabolic
changes has been reported for a number of widely expressed
transcription factors including NF-KB [49], some members of the
Fos/Jun family [50], p53 [51], and NF IL-6 [52], implying that a
large number of transcriptional systems may contribute to the
response to hypoxia. In view of this it has been rather surprising
that the transfection studies of cis-acting regulatory elements have
so commonly implicated HIF-1 in conveying responses to hypoxia
on different genes. An important opportunity to determine the
role of I-hF-I in transcriptional responses to hypoxia using
different methodology was therefore provided, following the
cloning of HIF-i [53], by the availability of mutant cells that are
defective for one component of the DNA binding complex [54].
Affinity purification and molecular cloning of HIF-I by Se-
menza and colleagues [53] demonstrated that the DNA binding
complex is composed of two basic-helix-loop-helix PAS proteins
termed HIF-lcs and HIF-i/3. HIF-ia was a newly defined member
of this family whereas HIF-113 had previously been identified as
the aryl hydrocarbon nuclear receptor translocator (ARNT), a
molecule previously identified by mutation and complementation
studies as essential for the transcriptional response to certain
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Fig. 3. Different sequences within the glucose transporter 5' enhancer convey
responses to hypoxia and mitochondrial inhibitors. The positions of serum
response element (SRE) and the HIF-1 Site are indicated within a 326 bp
sequence from the enhancer. Sequence containing a mutation in the SRE,
plasmid pG5'EfSRE)n, conferred regulation by hypoxia and cobalt but
not azide. Sequence containing a mutation in the HIF-1 site, plasmid
pG5'E(HIF)a, conferred regulation by azide but not by hypoxia or
cobalt. Values are related to the regulation conferred by the native
sequence, plasmid pG5'E [i—326]cr. Data are mean SE and are from
[34].
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environmental hydrocarbons termed the xenobiotic response [55,
56]. In this capacity ARNT forms a heterodimer with another
basic helix-loop-helix PAS protein, the ligand binding subunit
termed the aryl hydrocarbon receptor (AHR) [57]. This complex
binds the xenobiotic responsive element, a control sequence for
genes such as CYPJA1, a cytochrome P450 which can convert aryl
hydrocarbons to toxic or carcinogenic metabolites [58]. This
connection between two inducible responses to apparently distinct
environmental stimuli raises important questions as to the func-
tional and evolutionary links between the responses. It also
provided an important resource for the analysis of hypoxic gene
regulation in the form of mutant mouse hepatoma (Hepa-1) cells
originally selected for a defective xenobiotic response by survival
in the presence of benzo(a)pyrene. One group of these mutants
was shown to be defective in the nuclear translocation of the
ligand binding complex and provided the original basis for cloning
of the gene encoding ARNT by complementation [55, 56]. Since
ARNT and HIF-113 are identical, the ARNT deficient cells have
now provided a powerful tool for the analysis of hypoxic gene
regulation.
A comparison of HIF-1 DNA binding activity in the wild type
Hepa-1 cells and the ARNT line, c4 is shown in Figure 4. The
absence of the inducible HIF-1 complex in c4 cells indicates that
ARNT is an essential component of HIF-l, and has permitted
several approaches to the further analysis of this system.
By transfection of expression plasmids bearing wild-type or
deleted ARNT genes the functional requirement for different
domains of ARNT in the transcriptional response to hypoxia can
be tested [27]. An example of such a study is shown in Figure 5.
The basic, helix-loop-helix, and PAS domains that have predicted
functions in DNA binding and dimerization were all essential for
functional complementation. In contrast, amino and carboxyl
terminal deletion did not prevent functional complementation,
even though the construct omitted a powerful transcriptional
activation domain which has been mapped to the carboxyl termi-
nus of ARNT [59].
A second use of the ARNT cells is in the comparison of the
hypoxically inducible responses of endogenous genes between
wild-type, mutant, and complemented cells. In this way it is
possible distinguish very clearly the responses that are, or are not,
dependent on a functional ARNT gene product. We have sur-
veyed the expression of a large number of genes in a panel of
wild-type, mutant, complemented, and revertant Hepa-1 cells
[27]. These cells do not express erythropoietin but do express a
number of other hypoxically inducible genes. We examined exam-
ples of genes known to be inducible by hypoxia, and also newly
defined hypoxically inducible genes identified by differential dis-
play PCR [38]. Figure 6 shows data for a group of previously
identified hypoxically inducible genes. There were striking differ-
ences between wild-type and ARNT cells. For some genes, such
as LDH-A, the response to hypoxia was almost totally abrogated
in the ARNT - cells. In other cases, such as vascular endothelial
growth factor (VEGF), there was a clear reduction in the regu-
lation of mRNA levels by hypoxia but a definite inducible
response persisted. A third pattern of response was defined for
HIP-la itself where the induction of mRNA by hypoxia appeared
to be significantly greater in the ARNT cells than in the
wild-type.
Regulation of expression among a number of newly defined
hypoxically inducible genes identified by differential display PCR
Fig. 4. DNA binding assay for HIF-1 in wild-type Hepa-I cells and the
mutant derivative c4 which lacks a frmctional H1F-1 I3IARNT gene product.
Nuclear extract was incubated with double stranded oligonucleotide
containing the HIF-1 binding site from the mouse erythropoietin 3'
enhancer. Species binding the oligonucleotide retard the mobility with
respect to the free probe (FP). Both constitutive (Cons) and inducible
(md) binding complexes arc observed. The inducible complex correspond-
ing to HIF-1 is not observed in c4 cells.
conformed to these patterns. For example, the gene encoding
adenylate kinase 3 was induced approximately sixfold by hypoxia
in wild-type }Iepa-l cells but not in ARNT cells, whereas like
HIF-la, tissue factor mRNA was more inducible by hypoxia in the
ARNT cells than in the wild-type cells.
These responses clearly define both ARNT dependent and
ARNT independent mechanisms of gene regulation by hypoxia.
When cells were exposed to the iron chelator desferrioxamine,
patterns of response for the different genes were closely similar to
those defined for hypoxia, supporting the view that the actions of
the iron chelator are closely connected with the mechanism(s) of
oxygen sensing underlying both ARNT dependent and ARNT
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Fig. 5. Functional requirements for particular domains of the ARNT gene product in the hypoxic response. ARNT-c4 cells were co-transfected with a
reporter plasmid containing a HIF-1 binding site linked to a growth hormone (GH) reporter gene and ARNT expression plasmids containing the full
coding sequence or indicated deletions. (A) RNAse protection assay showing reporter gene expression (GH) and control plasmid expression (a) after
nornioxic (N) and hypoxic (H) incubations. Hepa-1 wild type cells and ARNT c4 cells transfected with only the reporter plasmids acted as positive
and negative comparisons (lanes 1 to 4). The inducible response in ARNT c4 cells is restored by transfection with the full coding sequence of
ARNT/HIF-l3 (lanes 5, 6) and also by the I3HLHAB truncated ARNT eDNA (lanes 7,8) but not the empty expression vector (lanes 9, 10). (B)
Schematic illustration of the ARNT/HIF-113 eDNA and deletions, together with the hypoxically inducible reporter gene expression observed in each
co-transfection assay. Values (mean SD) show the ratio of hypoxic to normoxic expression in parallel incubations of transfected cells. The number of
experiments is shown in parentheses. Domains are as indicated: b, basic; HLH, helix-loop-helix; PAS, Per-AHR-ARNT-Sim. Data are from [27].
independent mechanisms of gene regulation. Nevertheless, effects
of ARNT status on the inducible response to the two stimuli were
not identical, with somewhat better preservation of the response
to DFO in the ARNT cells demonstrating that some differences
amine must exist.
The profound abnormality of hypoxically inducible gene expres-
sion observed in ARNT cells indicates that studies of these cells
should provide important insights into the role of this system of
gene regulation in cell physiology. In pilot experiments we have
not observed a clear difference in cell growth as tissue culture
monolayers between wild-type Hepa-1 and c4 cells either at 20%
oxygen or at 1% oxygen. In contrast, in experiments performed in
collaboration with Dr. Gabi Dachs and Dr. Ian Stratford (Medical
Research Council Radiobiology Unit, Oxon, UK) we found that
tumor growth following transplantation to nude mice was mark-
edly different between the wild-type, mutant, and revertant cells.
Although initial growth rates were similar, beyond a certain size
wild-type tumors grew much much more quickly; they had better
developed vasculature and had less extensive regions of necrosis
than tumors of c4 cells. It therefore appears likely that, in keeping
with the existence of profound hypoxia within many types of
role in tumor biology.
Evolutionary origins of the transcriptional response to hypoxia.
A HIF-1 homologue in Drosophila
Oxygen regulated expression of highly conserved genes such as
those involved in glucose transport and glycolysis raises the
question as to the evolutionary conservation of the underlying
regulatory mechanism. Since functional sites of interaction be-
tween two or more molecules are often highly conserved, we
sought evidence for the evolutionary conservation of HIF-1 using
oligonucleotides from HIF-1 binding sites at mammalian erythro-
poietin and phosphoglycerate kinase-1 loci in binding reactions
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Fig. 6. Hypoxic induction of gene expression in Hepa-1 cells and ARNT c4 cells. Induction is the ratio of expression in hypoxia (1% oxygen) to that in
normoxia (20% oxygen). Normoxic expression is related to the abundance of 13-actin mRNA (arbitrarily assigned a value of 1,000). Each bar represents
the mean SD of at least 4 experiments. *statistically significant difference between the two cell types (U, Hepa-1 cells; , c4 cells), P < 0.05. Data
are from [271.
with nuclear extract prepared from insect cells (the Drosophila
melanogaster SL2 cell line) [60]. The insect cells were grown in
normoxic (20% oxygen) or hypoxic (1% oxygen) tissue culture
conditions and nuclear extract prepared using the modified Dig-
nam protocol used in the preparation of HIF-1 activity from
mammalian cells [61]. Figure 7 shows an electrophoretic mobility
shift assay (EMSA) using an oligonucleotide containing the HIF- I
binding site from the mouse erythropoietin 3' enhancer. Species
complexing with the labeled oligonucleotide retard its mobility
and appear as shifted bands. The extracts from insect cells were
shown to form an hypoxically inducible complex which has similar
DNA binding specificity, and mobility, to mammalian HIF-1 (Fig.
7A). Several other similarities between H IF-i and the Drosophila
complex (which we have termed HIF-D) were observed. In each
case formation of the inducible species was sensitive to cyclohex-
imide, implying a need for new protein synthesis at some stage in
the inducible process. Interestingly, as has been described for
HIF-1 [62], HIF-D is very sensitive to redox conditions. Omission
of the sulfhydiyl reducing agent, dithiothreitol from the prepara-
tive buffers or treatment with the sulfhydryl oxidizing agent
diamide abolished DNA binding of HIF-D in a reversible manner
(Fig. 7B). The remarkable in vitro sensitivity to such reagents
makes it tempting to suggest that sulfhydryl redox changes might
be an important mechanism of oxygen regulated activity of these
complexes in vivo. Unfortunately, determination of the redox
conditions that pertain in the intracellular microenvironment of
these proteins is not straightforward and there are insufficient
data to date to confirm or refute this possibility.
Several issues are raised by the demonstration of a HIF-1
homologue in Drosophila. The function and molecular identity of
HIF-D in Drosophila cells are unknown. The defining members of
the PAS groups of transcription factors were the Drosophila genes
Per and Sim. Neither are likely candidates for involvement in
HIF-D; Per is a circadian regulator of gene expression but itself
lacks a DNA binding domain [63], and Sim is a developmental
trascription factor directing spatially regulated gene expression in
the midline [641. Nevertheless, given the potential importance of
oxygen in the organization of growth in higher animals, it is
interesting that the Drosophila PAS genes for which function has
so far been defined are involved in the spatial and temporal
aspects of growth control.
Conservation between mammalian and insect cells suggests that
the system most probably has even more primitive origins. Using
similar methodology, we have attempted (thus far without suc-
cess) to demonstrate a HIF-1 homologue in yeast cells. Such a
negative result could, however, have a technical explanation; the
combination of a tough cell wall and poorly developed nuclear
membrane makes concentration of nuclear protein (as in the
Dignam protocol) difficult or impossible to achieve.
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Fig. 7. DNA binding assays using nuclear extract from Drosophila SL2 cells. (A) Sequence specific binding of a hypoxically inducible complex similar to
HTF-1 to an oligonucleotide from the mouse erythropoietin 3' enhancer (Ep0WT). The inducible species (I) is of similar mobility to HIF-1 derived from
mammalian HeLa cells (lanes I to 4). The inducible species is competed by unlabeled oligonucleotide, but not an olignnucleotide containing a four base
pair mutation destroying the HIF-I binding Site. (B) The DNA activity of the hypoxically inducible complex prepared from Drosophila cells (I) is
sensitive to sulfhydrl redox agent in vitro. Binding is reduced when dithiothreitrol (DTF) is omitted from the preparative buffers, ablated by treatment
with diamide (lanes 1 to 6), but can be restored by subsequent treatment with a high dose of DTT (lanes 7 and 8). Data are from 6O].
Oxygen sensing and signal transduction
Since the first recognition of this system of gene regulation in
the control of erythropoietin production, understanding of the
mechanism of oxygen sensing has been an important goal. In
theory, any process that is affected by oxygen in a concentration-
dependent manner could form the basis of sensing, though in the
case of the system under study here, many candidates might
reasonably be excluded by the apparent failure of mitochondrial
inhibitors to mimic the response. In the broadest sense, molecular
interactions with oxygen are of two types: redox-based systems in
which oxygen acts as an electron acceptor, and the reversible
liganding of dioxygen to metal ions as occurs in oxygen carrying
proteins such as hemoglobin. Oxygen dependent signals could be
generated in several ways and some general mechanisms are set
out in Figure 8. In the case of redox based systems a number of
different types of sensing mechanisms are possible. The reaction
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Fig. 8. Some potential mechanisms of oxygen sensing.
products (either a partially reduced active oxygen species, such as
superoxide, or an oxidized product such as a steroid molecule)
could act as signal pathway intermediates. Alternatively, a redox
enzyme could signal through redox based conformational changes.
Since a chain of redox reactions may take place with oxygen as the
terminal acceptor, signals could be generated by the redox status
of components quite distant from the reaction with oxygen. Quite
possibly the action of oxygen could be to divert electron flow from
an alternate (signaling) electron acceptor so that effectively a
switch of sign is achieved with high rates of electron flow
potentially able to signal hypoxia. This long list of theoretical
possibilities, together with the large number of known oxidases
make direct analysis of the mechanism of sensing difficult. Nev-
ertheless, several interesting insights have already been obtained.
Based on the pharmacological characteristics of gene induction
(particularly sensitivity to carbon monoxide) the involvement of a
hemoprotein has been postulated with the constitutive action of
cobalt being explained by the formation of constitutively-deoxy
cobalt protoporphyrin [9]. Though it seems difficult to accommo-
date all the characteristics of the system in the operation of a
simple hemoglobin-like molecule reversibly binding oxygen, the
involvement of hem-containing groups in more complex redox
based sensing mechanisms remains very plausible [65]. Other
workers have stressed the inhibition of gene induction by hydro-
gen peroxide and have suggested that this partially-reduced
reactive oxygen species could function as a signal pathway inter-
mediate with oxygen dependent production providing a sensing
mechanism [66, 67]. In this model it has been proposed that the
action of iron chelators might then be explicable through inhibi-
tion of iron dependent catalysis of radical production by the
Fenton reaction. We have noted that induction of the system by
hypoxia but not cobalt is very sensitive to the flavoprotein
inhibitor diphenylene iodonium [68]. This implies some difference
in cobalt induced activation, and also that the system might
involve the operation of a flavoprotein oxido-reductase [69]. Such
molecules are often coupled to haem proteins in electron trans-
port systems, for instance the flavoprotein cytochrome P450
reductase is coupled to many different hem-containing cyto-
chrome P450s, which perform a wide variety of oxygen dependent
reactions [70]. One or more of such reactions could be involved in
the oxygen sensing process. Since the HIF-1 related aryl hydro-
carbon receptor (AHR) is a ligand-binding transcription factor
activated by the binding of certain aryl hydrocarbons [58], and an
influence of P450 induction on erythropoietin regulation has
previously been demonstrated [71], it is tempting to speculate that
oxygen dependent generation of a P450 oxygenase reaction
product might provide a regulatory ligand for HIF-1.
Though the possibility of direct definition of the signaling
molecules by pharmacological probing is therefore attractive, the
potential complexity of biological reactions with oxygen remains
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Fig. 9. Definition of a regulatoty domain in HIF-la. (A) Schematic of the experimental design. Each basic-helix-loop-helix PAS protein coding sequence
was fused 3' to the DNA binding domain of the glucocorticoid receptor (GR500). Activation of the chimeric transcription factor was assayed by
co-transfeetion of ucLa cells with the glucocorticoid response promoter from the mouse mammary tumor virus (MMTV) linked to a luciferase reporter.
(B) Data for human HIF-lo, human HIF-lp/ARNT and mouse AHR chimeras. When compared to the truncated glucocorticoid receptor alone a
hypoxically inducible response was conveyed by sequences within HIF-la but not the other genes. (C) A regulatory domain from HIF-la (hHIF-la Mo)
is sufficient to convey hypoxic regulation when placed between the DNA binding domain of the transcription factor Ga14 and the otherwise constitutive
transactivation domain of HTF-113/ARNT (hARNT TA). In this experiment the reporter plasmid contained yeast Gal4 binding upstream activating
sequences (UAS) linked to a thymidine kinase promoter (TK) linked to luciferase coding sequences (Luc). Amino acid co-ordinates of each gene are
indicated in the schematic diagrams.
formidable. A similar problem is encountered in dissecting the could take place directly in the nucleus. However, more likely is
signal transduction mechanism. Because the mechanism(s) and the operation of a signal transduction pathway from an extranu-
intracellular site(s) of oxygen sensing are unknown it is theoreti- clear site of sensing. Protein phosphorylation is commonly used in
cally possible that activation of transcription factor by hypoxia such transduction mechanisms. Both the sensitivity of hypoxic
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gene induction to protein kinase inhibitors [72—76], and evidence
indicating that HIF-1 is a phosphoprotein [74], provide support
for involvement of such processes in the inducible response.
However, as with the oxygen sensing mechanism itself, the
number of candidate molecules is large, making molecular iden-
tification from the use of pharmacological inhibitors difficult. For
instance, predictions from model genome sequence analyses such
as Caenorhabditis elegans indicate the likely existence of approx-
imately 3000 human genes encoding protein kinases or phospha-
tases [77, 78]. The use of targeted mutation to create specific
disabling mutations together with the transfection of dominantly
interferring mutant genes may offer a more specific approach to
the problem. Of potential interest was a recent report using such
methodology to implicate the protein tyrosine kinase c-src in the
hypoxic induction of VEGF mRNA [75]. However, using c-src
deficient cells, and the overexpression of active or dominantly
interferring mutant c-src genes, we have been unable to demon-
strate involvement of c-src in the regulation of HIF-1, nor do our
data provide any support for the original demonstration of
involvement in the hypoxic regulation of VEGF mRNA [79].
Activation of HIF-!
Analysis of the molecular mechanism(s) underlying the activa-
tion of HJF-1 allows a potentially more secure route to under-
standing the proximal mechanisms involved in oxygen sensing and
signal transduction. In studies of hypoxic tissue culture cells and
anaemically stimulated mice we did not observe high level hypoxic
induction of the mRNAs encoding either HIF-Irs or HIF-lp,
indicating that the major regulatory mechanisms are either trans-
lational or post-translational. Many transcription factors contain
distinct domains involved with DNA binding, dimerization, or
transcriptional activation [431 and regulatory mechanisms could
be involved in some or all of these processes. To define regulatory
interactions in transcriptional activation by HIF-1, we have cre-
ated series of chimeric genes in which the whole or portions of the
HIF-1 coding sequence are fused to the DNA binding domain of
another transcription factor. Figure 9A shows the design of such
an experiment in which the HIF-1 gene is fused to the N terminus
of the glucocorticoid receptor. The N-terminal glucocorticoid
receptor sequences encode the DNA binding domain of the
molecule; they also provide a nuclear localization signal and have
some transactivation function. However, they lack the ligand
binding domain and show constitutive transcriptional activity. In
the series of experiments illustrated in Figure 9B, HIF-lcs,
HIF-1/ARNT, and AHR coding sequences were fused to this
sequence, and the inducible activity of such chimeric genes was
tested by co-transfection of HeLa cells together with a reporter
plasmid containing a glucocorticoid responsive promoter linked to
the luciferase reporter gene. HIF-la sequences, but not those
encoding the dimerization partner HIF-1f3/ARNT, or the related
PAS protein, AHR, conveyed hypoxically inducible regulation on
the glucocorticoid receptor reporter system, indicating that one or
more sequences in the HIF-lu protein has a regulatory function.
When other conditions were tested, this response was found to
mimic the inducible characteristic of HIF-1 itself. Induction of
similar magnitude was observed in response to cobaltous ions and
the iron chelator desferrioxamine, but was not observed when
cells were exposed to the metabolic inhibitors cyanide and azide.
Such a system has great advantages for the analysis of a regulatory
mechanism, since the portion of the molecule responsible for the
inducible property can be isolated from other functions. In
keeping with this, inducible activity of transfected HIF-Ics chi-
meric genes was also observed in the ARNT c4 cells demon-
strating an independence from ARNT function. Deletion and
mutational analysis has been performed to define more accurately
the regulatory sites and mechanisms. These experiments have
defined a C-terminal transactivation domain in HIF-Ics, and a
regulatory domain which lies 5' to this region. This regulatory
domain can convey the hypoxically inducible activity on other
heterologous systems. An example of such an experiment is shown
in Figure 9C. Here the N-terminal portion of the chimeric gene is
provided by the DNA binding domain of the yeast transcription
factor Ga14, which can activate a co-tranfected reporter plasmid
containing a Ga14 binding site in the promoter. The regulatory
domain of HIF-la is shown to convey hypoxic induction by
interaction with the otherwise constitutive transactivation domain
from the HIF-1/3/ARNT gene. Though there are likely to be many
mechanisms of regulation of HIF-1, these experiments indicate
that it should be informative to define this mechanism in detail.
Such experiments are ongoing, but it is of interest that the region
contains a number of interesting motifs including potential phos-
photylation sites and sequences enriched in PEST (proline,
glutamic acid, serine, and threonine) residues which have been
implicated as signals for rapid proteolysis.
In summary, studies arising from the analysis of erythropoietin
regulation have provided evidence for a widely operative system
of gene control that appears to respond specifically to oxygen, and
to be involved in a large number of physiological and pathophys-
iological processes. Definition of the mechanisms of sensing and
signal transduction is now an important challenge.
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